344 related articles for article (PubMed ID: 35360111)
1. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.
Martin S; Battistini C; Sun J
Front Cell Infect Microbiol; 2022; 12():839526. PubMed ID: 35360111
[TBL] [Abstract][Full Text] [Related]
2. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
5. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Zhang YG; Wu S; Yi J; Xia Y; Jin D; Zhou J; Sun J
Clin Ther; 2017 Feb; 39(2):322-336. PubMed ID: 28129947
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence.
Sun J; Huang T; Debelius JW; Fang F
J Intern Med; 2021 Oct; 290(4):758-788. PubMed ID: 34080741
[TBL] [Abstract][Full Text] [Related]
7. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in ALS: possible role in pathogenesis?
McCombe PA; Henderson RD; Lee A; Lee JD; Woodruff TM; Restuadi R; McRae A; Wray NR; Ngo S; Steyn FJ
Expert Rev Neurother; 2019 Sep; 19(9):785-805. PubMed ID: 31122082
[No Abstract] [Full Text] [Related]
9. Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions.
Chen S; Cai X; Lao L; Wang Y; Su H; Sun H
Aging Dis; 2024 Feb; 15(1):74-95. PubMed ID: 37307822
[TBL] [Abstract][Full Text] [Related]
10. The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review.
Erber AC; Cetin H; Berry D; Schernhammer ES
Int J Neurosci; 2020 Jul; 130(7):727-735. PubMed ID: 31870202
[No Abstract] [Full Text] [Related]
11. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.
Moțățăianu A; Șerban G; Andone S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894774
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology.
Lyon MS; Wosiski-Kuhn M; Gillespie R; Caress J; Milligan C
Muscle Nerve; 2019 Jan; 59(1):10-22. PubMed ID: 29979464
[TBL] [Abstract][Full Text] [Related]
13. Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Blacher E; Bashiardes S; Shapiro H; Rothschild D; Mor U; Dori-Bachash M; Kleimeyer C; Moresi C; Harnik Y; Zur M; Zabari M; Brik RB; Kviatcovsky D; Zmora N; Cohen Y; Bar N; Levi I; Amar N; Mehlman T; Brandis A; Biton I; Kuperman Y; Tsoory M; Alfahel L; Harmelin A; Schwartz M; Israelson A; Arike L; Johansson MEV; Hansson GC; Gotkine M; Segal E; Elinav E
Nature; 2019 Aug; 572(7770):474-480. PubMed ID: 31330533
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis.
Guo K; Figueroa-Romero C; Noureldein MH; Murdock BJ; Savelieff MG; Hur J; Goutman SA; Feldman EL
Brain; 2024 Feb; 147(2):665-679. PubMed ID: 37721161
[TBL] [Abstract][Full Text] [Related]
15. Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis.
Niccolai E; Martinelli I; Quaranta G; Nannini G; Zucchi E; De Maio F; Gianferrari G; Bibbò S; Cammarota G; Mandrioli J; Masucci L; Amedei A
Methods Mol Biol; 2024; 2761():373-396. PubMed ID: 38427251
[TBL] [Abstract][Full Text] [Related]
16. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: establishment of bacterial and archaeal communities analyses.
Zhai CD; Zheng JJ; An BC; Huang HF; Tan ZC
Chin Med J (Engl); 2019 Aug; 132(15):1815-1822. PubMed ID: 31306225
[TBL] [Abstract][Full Text] [Related]
17. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients.
Zeng Q; Shen J; Chen K; Zhou J; Liao Q; Lu K; Yuan J; Bi F
Sci Rep; 2020 Aug; 10(1):12998. PubMed ID: 32747678
[TBL] [Abstract][Full Text] [Related]
18. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
Lee A; Henderson R; Aylward J; McCombe P
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339149
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls.
Hertzberg VS; Singh H; Fournier CN; Moustafa A; Polak M; Kuelbs CA; Torralba MG; Tansey MG; Nelson KE; Glass JD
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Feb; 23(1-2):91-99. PubMed ID: 33818222
[No Abstract] [Full Text] [Related]
20. The fecal microbiome of ALS patients.
Brenner D; Hiergeist A; Adis C; Mayer B; Gessner A; Ludolph AC; Weishaupt JH
Neurobiol Aging; 2018 Jan; 61():132-137. PubMed ID: 29065369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
